Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
1.400
+0.100 (7.69%)
At close: Dec 20, 2024, 4:00 PM
1.420
+0.020 (1.42%)
After-hours: Dec 20, 2024, 6:35 PM EST
RANI Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
140
Market Cap
80.40M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | 2.72M | 2.26M | 488.10% |
Dec 31, 2020 | 462.00K | -517.00K | -52.81% |
Dec 31, 2019 | 979.00K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Theratechnologies | 84.32M |
Generation Bio Co. | 18.58M |
InspireMD | 6.82M |
I-Mab | 3.31M |
Ikena Oncology | 659.00K |
Ovid Therapeutics | 631.70K |
Genelux | 8.00K |
RANI News
- 2 months ago - Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants - GlobeNewsWire
- 2 months ago - Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit - GlobeNewsWire
- 3 months ago - Rani Therapeutics to Participate in September Investor Conferences - GlobeNewsWire
- 4 months ago - Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update - GlobeNewsWire
- 5 months ago - Rani Therapeutics to Participate in August Investor Conferences - GlobeNewsWire
- 5 months ago - Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering - GlobeNewsWire
- 6 months ago - Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment - GlobeNewsWire
- 7 months ago - Rani Therapeutics to Participate in May Investor Conferences - GlobeNewsWire